Ignite Creation Date:
2024-05-06 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 2:31 PM
Study NCT ID:
NCT05360680
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2022-04-19
Brief Title:
A Phase 1 in Patients With HLA-A0201 and WT1 RecurrentMetastatic Cancers
Sponsor:
Cue Biopharma
Organization:
Cue Biopharma